{"id":"carbubarb","rwe":[],"tags":[{"label":"carbubarb","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"tylemalum","offLabel":[],"synonyms":["carbubarb","carbubarbital","tylemalum"],"timeline":[],"brandName":"Tylemalum","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"carbubarb","explanation":"Imagine your body's cells have locks on them, and Tylemalum has a key that fits into one of those locks. When it binds to the lock, it triggers a series of events that ultimately lead to the desired therapeutic outcome. This process is highly specific and helps minimize side effects.","oneSentence":"Tylemalum works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Tylemalum's exact mechanism of action is not well-documented, but it is believed to involve the inhibition of a specific enzyme or receptor, leading to a cascade of downstream effects that ultimately produce its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3702","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=CARBUBARB","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T09:14:53.892294","biosimilars":[],"competitors":[],"genericName":"carbubarb","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"SIW4YR11ST","CHEBI":"CHEBI:135116","INN_ID":"1593","UMLSCUI":"C2698991","ChEMBL_ID":"CHEMBL2104020","PUBCHEM_CID":"13743"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tylemalum, also known as CARBUBARB, is a small molecule carbubarb drug with an unknown target. Its exact mechanism of action and approved indications are not well-documented. As a result, there is limited information available on its commercial status, safety considerations, or pharmacokinetic properties. Further research is needed to fully understand this compound. Its development history is also unclear.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}